Clinical Trial Update: Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating three modalities of treatment in operable and resectable Stage IIIA (T1-3, N2) non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED